BioCentury | Apr 9, 2021
Management Tracks

Bryce joins Rain as CMO; plus Ichnos, Dementia Discovery Fund, Akoya and more

...NYSE:ABBV).Akoya Biosciences Inc. hired Frederic Pla as COO. Pla previously served as COO at the Parker Institute for Cancer Immunotherapy...
BioCentury | Jan 8, 2021
Deals

ArsenalBio reaches next stage of maturity with BMS deal

...solid tumor targets chosen by BMS.ArsenalBio as among the first companies to originate from the Parker Institute for Cancer Immunotherapy...
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...basis. Immunotherapy play 3T Biosciences appointed John Connolly as interim CEO. Connolly is CSO at the Parker Institute for Cancer Immunotherapy...
BioCentury | Jul 18, 2020
Management Tracks

Genzyme vet Modur joins Zikani; plus Scholar Rock, Poseida, Ribon, Kiadis and more

...and CMO of Tizona Therapeutics Inc. and also serves as a medical adviser to the Parker Institute for Cancer Immunotherapy...
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...formed scientific advisory board of Ziopharm Oncology Inc. (NASDAQ:ZIOP). He is director of both the Parker Institute for Cancer Immunotherapy...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...and Neikirk is chair of the Children’s Hospital of The King’s Daughters Children’s Health System. Parker Institute for Cancer Immunotherapy...
...COO. He was COO of Genomic Health Inc. (NASDAQ:GHDX). Robin Sawka, BioCentury Staff Grail Inc. Notable Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt...
BioCentury | Mar 9, 2020
Deals

Lonza ‘cocoons’ give academics route to scale autologous cell therapies

...a research collaboration with Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy...
...CAR T to India” ). Karen Tkach Tuzman, Associate Editor Lonza Group Ltd. Fred Hutchinson Cancer Research Center Stanford University Parker Institute for Cancer Immunotherapy Immuneel...
BioCentury | Feb 21, 2020
Product Development

T regs are back - promising to do for autoimmunity what CAR Ts have done in cancer

...headed by T cell pioneer Jeffrey Bluestone, who was previously president and CEO of the Parker Institute for Cancer Immunotherapy...
BioCentury | Feb 7, 2020
Emerging Company Profile

Led by Bluestone, Sonoma launches to turn Tregs against autoimmunity

...to create durable and “functionally superior” cells. Bluestone, who became president and CEO of the Parker Institute for Cancer Immunotherapy...
BioCentury | Dec 27, 2019
Company News

Two-year-old Xyphos gains exit as Astellas scoops up CAR T switch platform

...said it got a “huge shot in the arm” from a 2018 partnership with the Parker Institute for Cancer Immunotherapy...
Items per page:
1 - 10 of 55
BioCentury | Apr 9, 2021
Management Tracks

Bryce joins Rain as CMO; plus Ichnos, Dementia Discovery Fund, Akoya and more

...NYSE:ABBV).Akoya Biosciences Inc. hired Frederic Pla as COO. Pla previously served as COO at the Parker Institute for Cancer Immunotherapy...
BioCentury | Jan 8, 2021
Deals

ArsenalBio reaches next stage of maturity with BMS deal

...solid tumor targets chosen by BMS.ArsenalBio as among the first companies to originate from the Parker Institute for Cancer Immunotherapy...
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...basis. Immunotherapy play 3T Biosciences appointed John Connolly as interim CEO. Connolly is CSO at the Parker Institute for Cancer Immunotherapy...
BioCentury | Jul 18, 2020
Management Tracks

Genzyme vet Modur joins Zikani; plus Scholar Rock, Poseida, Ribon, Kiadis and more

...and CMO of Tizona Therapeutics Inc. and also serves as a medical adviser to the Parker Institute for Cancer Immunotherapy...
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...formed scientific advisory board of Ziopharm Oncology Inc. (NASDAQ:ZIOP). He is director of both the Parker Institute for Cancer Immunotherapy...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...and Neikirk is chair of the Children’s Hospital of The King’s Daughters Children’s Health System. Parker Institute for Cancer Immunotherapy...
...COO. He was COO of Genomic Health Inc. (NASDAQ:GHDX). Robin Sawka, BioCentury Staff Grail Inc. Notable Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt...
BioCentury | Mar 9, 2020
Deals

Lonza ‘cocoons’ give academics route to scale autologous cell therapies

...a research collaboration with Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy...
...CAR T to India” ). Karen Tkach Tuzman, Associate Editor Lonza Group Ltd. Fred Hutchinson Cancer Research Center Stanford University Parker Institute for Cancer Immunotherapy Immuneel...
BioCentury | Feb 21, 2020
Product Development

T regs are back - promising to do for autoimmunity what CAR Ts have done in cancer

...headed by T cell pioneer Jeffrey Bluestone, who was previously president and CEO of the Parker Institute for Cancer Immunotherapy...
BioCentury | Feb 7, 2020
Emerging Company Profile

Led by Bluestone, Sonoma launches to turn Tregs against autoimmunity

...to create durable and “functionally superior” cells. Bluestone, who became president and CEO of the Parker Institute for Cancer Immunotherapy...
BioCentury | Dec 27, 2019
Company News

Two-year-old Xyphos gains exit as Astellas scoops up CAR T switch platform

...said it got a “huge shot in the arm” from a 2018 partnership with the Parker Institute for Cancer Immunotherapy...
Items per page:
1 - 10 of 55